{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:52:08Z","timestamp":1790945528293,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Rasa Hamilton"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.lungcan.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:31:14Z","timestamp":1498249874000},"page":"135-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results"],"prefix":"10.1016","volume":"111","author":[{"given":"J. Kevin","family":"Hicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Saller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhanelle E.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2017.06.015_bib0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc.2016.56","article-title":"Biomarker development in the precision medicine era: lung cancer as a case study","volume":"16","author":"Vargas","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2017.06.015_bib0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research N","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2017.06.015_bib0015","doi-asserted-by":"crossref","first-page":"e0140712","DOI":"10.1371\/journal.pone.0140712","article-title":"Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA","volume":"10","author":"Lanman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2017.06.015_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.015_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020264","article-title":"Circulating cell free tumor DNA detection as a routine tool for Lung cancer patient management","volume":"18","author":"Vendrell","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2017.06.015_bib0030","article-title":"Comparison of 2 commercially available next-generation sequencing platforms in oncology","author":"Kuderer","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lungcan.2017.06.015_bib0035","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-06-3043","article-title":"KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"13","author":"Massarelli","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2017.06.015_bib0040","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1158\/1078-0432.CCR-05-2845","article-title":"Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation","volume":"12","author":"Han","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2017.06.015_bib0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1634\/theoncologist.2016-0195","article-title":"Key lessons learned from Moffitt's molecular tumor board: the clinical genomics action committee experience","volume":"22","author":"Knepper","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2017.06.015_bib0050","article-title":"Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from TATTON phase Ib trial","author":"Ahn","year":"2016","journal-title":"European Lung Cancer Conference (ELCC) 2016 meeting (Geneva, Switzerland). Abstract#1360"},{"key":"10.1016\/j.lungcan.2017.06.015_bib0055","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S1470-2045(16)30562-9","article-title":"Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial","volume":"17","author":"Drilon","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2017.06.015_bib0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-2600(16)30322-8","article-title":"Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial","volume":"5","author":"Yoh","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lungcan.2017.06.015_bib0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1256930","article-title":"Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing","volume":"346","author":"Zhang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2017.06.015_bib0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.2012.581","article-title":"Cancer heterogeneity: implications for targeted therapeutics","volume":"108","author":"Fisher","year":"2013","journal-title":"Br. J. Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217303689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217303689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T08:52:07Z","timestamp":1535705527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500217303689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":14,"alternative-id":["S0169500217303689"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.06.015","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}